Topol, Wyss-Coray Studies Map Organ Aging in 60,000 People, Sharpening Early Disease Prediction
Updated
Updated · The Times of India · Aug 13
Topol, Wyss-Coray Studies Map Organ Aging in 60,000 People, Sharpening Early Disease Prediction
3 articles · Updated · The Times of India · Aug 13
Summary
A blood-based organ-aging report could soon estimate the biological age of the heart, brain, liver and other organs, using signatures identified across 60,000 people.
The approach reads organ-specific proteins that leak into blood, shifting diagnosis from age-based screening rules to personalized detection of which organ is aging fastest.
Research cited in the report found immune-cell aging predicted future diabetes before blood sugar turned abnormal, while lung-cell aging flagged cancer risk even after accounting for smoking.
In Alzheimer’s, 62-year-old APOE4 carriers with older astrocyte clocks developed disease about 38% of the time over 15 years, versus 13% for normally aging astrocytes; none of the 23 youngest-clock carriers did.
The tests are not yet widely commercialized, though protein profiling in UK Biobank has run at roughly $50 per person at scale, suggesting routine use could be 1-2 years away.
If AI can spot hidden disease in cell structures, are our internal organs ticking much faster than our chronological age suggests?
Could a routine blood test soon reveal which of your organs is secretly aging faster than the rest of your body?
Measuring Aging Organ by Organ: How AI Tissue Clocks Are Transforming Medicine, Drug Discovery, and Health Equity
Overview
In August 2026, researchers led by André Rendeiro revolutionized aging science by using AI to analyze the microscopic structure of human tissues, creating 'tissue clocks' that measure the biological age of each organ separately. Unlike traditional epigenetic clocks, which are less accurate across diverse populations and can't capture organ-specific aging, these AI models learned to ignore technical slide imperfections and focus on true biological signals. By linking tissue-derived age gaps to blood-based gene expression, the team enabled non-invasive predictions of organ health. This breakthrough highlights how lifestyle choices and early organ aging can drive disease, but also raises concerns about equity, as advanced longevity tools remain accessible mainly to the wealthy, deepening the healthspan divide.